Tofacitinib Benefits Sustained for Two Years in Patients With RA
Safety, tolerability through 24 months was consistent with 12-month tofacitinib analysis
CDC Examines Safety of Recombinant Zoster Vaccine
Total of 4,381 reports of adverse events during first eight months of use; 3 percent were serious
Expanded Recall of Warfarin Level Monitoring Test Strips
Inaccurate results may put patients at risk for serious injury or death
January 2019 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for January 2019. This roundup includes the latest...
Longitudinal TNF Levels Mainly Stable With Adalimumab in RA
Early low TNF strongly associated with formation of antidrug antibodies, may predict nonresponse
Pharmacist-Led Phone Follow-Up May Cut Readmission Rates
Intervention for polypharmacy patients linked to improved readmission rates, time to readmission
Direct-to-Doctor Payments May Increase Opioid Prescribing
Prescribers receiving opioid-specific payments prescribed 8,784 more opioid daily doses per year
Discontinuing TNFi Before Gestational Week 20 Is Feasible
No clinically meaningful disease worsening among women with well-controlled RA, juvenile arthritis
Physician Burnout Tied to Ability to Address Social Needs
Risk for burnout lower in clinics with social worker, pharmacist on care team
Shortage of Anxiety Drug Creates Alarm Among Patients, Doctors
Buspirone price has fallen so low that many manufacturers claim they cannot make a profit on it
